http://www.researchraven.com/conferences/category/depression.aspx en-us ResearchRaven 2013-06-19T20:34:17Z ResearchravenConferencesFeed-Depressionhttp://feedburner.google.com http://www.researchraven.com/conference/2014/6/22/4th-international-regional-north-america-stress-and-behavior-conference.aspx <p> 4th International Regional (North America) Stress and Behavior Conference</p> <p> June 22-24, 2014 New Orleans, Louisiana</p> <p> An annual international event gathering scientists and psychiatrists from around the world to share an interest in stress-evoked brain disorders in both humans and animals.</p> <p> Conference Secretariat</p> <p> Tel: + 1 (240) 899-9571</p> <p> info@stressandbehavior.com</p> <p> <a href="mailto:isbs.congress@gmail.com">isbs.congress@gmail.com</a></p> ResearchRaven http://www.researchraven.com/conference/2014/3/27/anxiety-and-depression-conference-2014.aspx <p> Anxiety and Depression Conference 2014</p> <p> Personalized Treatments for Anxiety and Mood Disorders</p> <p> March 27-30, 2014 Chicago, Illinois</p> <p> The Anxiety and Depression Association of America (ADAA) leads the way in bringing together a multidisciplinary community of basic and clinical researchers and clinicians with diverse backgrounds in psychiatry, psychology, social work, counseling, nursing, neuroscience, and more. ADAA sponsors the only conference focusing exclusively on science and treatment of anxiety and depression, including but not limited to generalized anxiety disorder, OCD, PTSD, panic disorder, social anxiety disorder, phobias, depression, and related disorders in children and adults. Submissions are welcome on a broad range of research and practice topics relating to these disorders.</p> <p> For Clinicians and Researchers</p> <p> The conference creates an essential bridge between clinicians and researchers. The overall goal is to improve patient outcomes by advancing dissemination and implementation of research and providing experiential learning about evidence-based treatments and best practices in real-world settings.</p> <p> Theme: Personalized Treatments for Anxiety and Mood Disorders</p> ResearchRaven http://www.researchraven.com/conference/2013/9/18/accelerating-translational-neurotechnology-fourth-annual-aspen-brain-forum.aspx <p> Accelerating Translational Neurotechnology: Fourth Annual Aspen Brain Forum</p> <p> September 18 - 20, 2013 Aspen Meadows Resort</p> <p> Presented by The Aspen Brain Forum Foundation, Science Translational Medicine, and the New York Academy of Sciences</p> <p> Neurotechnology encompasses electrical, chemical, and medical devices and products that can interact with or intervene in the activity of the central nervous system. These technologies include neuroprosthetics, neuroengineering, neuroimaging, optogenetics, neuromodulation, and neural stem cell therapies. Translating neurotechnologies from the laboratory into clinical and commercial products has been an arduous process. Yet many of these new tools show great potential to revolutionize the treatment of neurological diseases and disorders including depression, pain, headache, epilepsy, neuromuscular disease, Alzheimer&#39;s disease, Parkinson&#39;s disease, and traumatic brain injury.</p> <p> Through a series of plenary sessions, panel discussions, and interactive breakout groups, this 2.5-day international conference shall explore innovative scientific, clinical, and organizational models for advancing the translation of neuroscience research into technology that can dramatically improve diagnosis and treatment of neurological and psychiatric disease. Participants will also examine the ethical and regulatory challenges in translating neuroscience research, and the potential economic impact of their clinical application.</p> <p> This conference includes a breakout session. During registration, you will be asked to choose a work group based on your area/disease of interest. Please pick your first and second choices for this session. You may also write in an alternate topic. We will create additional groups if there is sufficient interest. Registrants will receive an email with work group details several weeks prior to the conference.</p> <p> Choices include: Parkinson&#39;s Disease, Major Depression and other Mood Disorders, Chronic Pain, Alzheimer&#39;s Disease, or Traumatic Brain Injury.</p> ResearchRaven http://www.researchraven.com/conference/2014/4/28/7th-biennial-congress-of-the-international-society-of-affective-disorders.aspx <p> 7th Biennial Congress of the International Society of Affective Disorders</p> <p> 28th &ndash; 30th April, 2014 Berlin, Germany</p> <p> Affective disorders: integrated approaches for the 21st century</p> <p> Join us at the Intercontinental in Berlin for the 7th Biennial Congress of The International Society of Affective Disorders, 28th &ndash; 30th April, 2014.</p> <p> This major international conference aims to promote networking, exchange of ideas and experiences, and advance awareness of the consequence of mental health to global health and human development.</p> <p> Although the affective disorders are not a clearly delineated group of illnesses they include unipolar and bipolar depression, generalised anxiety disorder, and more specific anxiety disorders such as agoraphobia, panic disorder and social phobia, obsessive-compulsive disorder and post-traumatic stress disorder (PTSD). There is a high level of similarity and co-morbidity among these illnesses and it is sensible to consider them as a single group.</p> <p> Join us at ISAD 2014 if you are a clinical practitioner, clinical researcher, industry professional, nurse or other healthcare practitioners interested in affective disorders</p> ResearchRaven http://www.researchraven.com/conference/2013/10/24/25th-annual-psychiatric-pharmacotherapy-update.aspx <p> 25th Annual Psychiatric Pharmacotherapy Update</p> <p> October 24 &amp; 25, 2013 Austin, Texas</p> <p> The University of Texas at Austin College of Pharmacy is proud to be hosting the 25th Annual Psychiatric Pharmacotherapy Update, October 24 &amp; 25, 2013 in Austin, Texas.&nbsp; This educational conference is presented by the College of Pharmacy&#39;s Continuing Pharmacy Education department and Psychiatric Pharmacy Program to meet the educational needs of practitioners who provide care to patients with mental health disorders.</p> <p> Addressing Psychiatric Pharmacotherapy Topics Important for Today&#39;s Practice</p> <p> This conference&#39;s goal is improve the quality of care delivered to people with mental health problems by providing timely and clinically useful information for the practicing clinician. Conference speakers focus on the practical application of neuroscience principles and evidence-based approaches to the treatment of serious and persistent major psychiatric and neurologic disorders, including depression, schizophrenia, bipolar, and dementias. Participants are provided with treatment advances in the psychiatric pharmacotherapy of children, traumatic brain injury, substance abuse, and an update on new psychotherapeutic uses of existing agents and new psychotropic agents that will impact your practice in the next year.</p> <p> Inter-Professional</p> <p> &bull; Pharmacists</p> <p> &bull; Psychiatrists</p> <p> &bull; Physicians</p> <p> &bull; Nurses</p> <p> &bull; Psychologists</p> <p> &bull; Social Workers &amp; Counselors<br /> <br /> Who Should Attend</p> <p> Pharmacists, psychiatrists, physicians, nurses, psychologists and social workers who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice.&nbsp;</p> ResearchRaven http://www.researchraven.com/conference/2013/7/9/melancholy-minds-and-painful-bodies-genealogy-geography-pathogeny.aspx <p> Melancholy Minds and Painful Bodies: Genealogy, Geography, Pathogeny</p> <p> University of Liverpool, United Kingdom 9-11 July 2013</p> <p> One of the major developments in the study of melancholia over the last thirty years has been the rise to aesthetic and cultural prominence of varieties of negative emotions proposed and discussed as melancholy, including different conceptions, analyses, and portrayals from grief to insanity. Most recently, Lars von Trier&rsquo;s film Melancholia(2011) happens to be the melodramatic adaptation of the concept fuelled by cinematic symbols. Correspondingly, often observed as &lsquo;a central European discourse&rsquo;, melancholia has resurfaced to embody complementary or paradoxical notions not merely in the literary analysis of texts and contexts, but it has also emerged to retrieve its historical categorization. The cultural and social history of emotions entwined with modern medical and psychiatric lexicalization has opened new pathways to provide relative definitions of melancholia. However, theories about the choice of analogies for melancholy, whether aesthetic, cinematic, religious, or medical, somehow fail to distinguish the connections between contrary factors involved in melancholia.</p> <p> It is also noteworthy that theories of characterization, no matter of what kind, tend to reformulate and evaluate contrary factors for the sake of preserving &lsquo;superiority&rsquo; according to prevalent taste at each moment in time. In Britain, for example, individual and collective melancholia has been appreciated as a sign of genius and national pride at one time and announced as a national malady at another. Analogous is the contemporary history of behavioural rather than cognitive attributes to grief, e.g. tearfulness. Pain, in comparison, is bodily and often mental distress which in the past was closely perceived in relation to melancholia, but today research on pain is divorced from depression let alone melancholy. Thus, we miss the &lsquo;melancholy-pain bridge&rsquo; in contemporary scholarship of mental and physical suffering. On the other hand, while pain is seen through the lens of universality, with management models stretching from Chinese medicine to Latin America, melancholia has rarely been investigated beyond the Western borders with regard to its genealogy, pathology, pathogeny, and management. Whether this geographical focus is a matter of re-establishing pre-eminence or in want of psycholinguistic reference, thereby centred on a gap in universal scientific communication, it invites intriguing and challenging enquiries.</p> <p> Possible topics</p> <p> Diversity in the geography of melancholia and pain<br /> The relationship between Western theories of emotions and Oriental conceptions<br /> The European hypothesis of melancholia-pain in non-European cultures<br /> Orientalism, grief, and abstinence<br /> Emotionality as negativity<br /> Gender attributes and tearfulness<br /> Art history, muscle tension, and the painful posture<br /> Interpretation, assumption, semantic relation<br /> Fear, Pain, and melancholy dominance<br /> Depression and pain<br /> Paranoia, melancholia, and pain<br /> Misconceptions; cyclothymia and bipolar disorder<br /> Melancholy appropriation, ethnicity, multicultural perspectives<br /> Cosmology and elegiac pain management<br /> Cinematic symbols<br /> Literary emotionality, fictive superiority<br /> Embodied cognition<br /> Anaesthetics, the relationship between medical management and other models<br /> Lyric manifestation of melancholy and pain</p> ResearchRaven